Related Experiment Video

Updated: Aug 1, 2026

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

Myocardial changes in malignant hyperthermia

J J Fenoglio, N S Irey

    The American Journal of Pathology
    |October 1, 1977
    PubMed

    Insights

    Malignant hyperthermia causes direct cardiac muscle damage, leading to ventricular arrhythmias. This study reveals cardiac myofiber damage, suggesting it

    Area of Science:

    • Cardiology
    • Pathology
    • Genetics

    Background:

    • Malignant hyperthermia (MH) is a pharmacogenetic disorder.
    • Skeletal muscle pathology in MH is well-documented.
    • Cardiac complications like ventricular fibrillation are common in MH patients.

    Observation:

    • Necropsy findings in 3 MH patients revealed cardiac contraction bands and myofiberlysis.
    • Ultrastructural analysis showed sarcolemma disruptions associated with myofiber damage.
    • These cardiac findings mirror skeletal muscle pathology in MH.

    Findings:

    • Direct damage to cardiac muscle, not solely hyperkalemia, likely causes ventricular arrhythmias in MH.
    • Myofiber overstretching and lysis are key pathological features in the MH heart.

    Implications:

    • Understanding cardiac pathology is crucial for managing MH-related arrhythmias.
    • This research highlights the direct impact of MH on cardiac integrity.
    • Further investigation into cardiac-specific MH treatments may be warranted.

    More Related Videos

    A Preclinical Model of Exertional Heat Stroke in Mice08:22

    A Preclinical Model of Exertional Heat Stroke in Mice

    Published on: July 1, 2021

    Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model13:41

    Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

    Published on: January 13, 2023

    Related Concept Videos

    Myocarditis I: Introduction01:21

    Myocarditis I: Introduction

    Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
    Myocarditis II: Clinical Features and Diagnostic Tests01:27

    Myocarditis II: Clinical Features and Diagnostic Tests

    Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
    Myocarditis IV: Nursing Management01:22

    Myocarditis IV: Nursing Management

    Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...